Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EXXA $1.7 WINS HUGE CHRYSLER CONTRACT!!!
EXX/A……PROFITABLE and LOW FLOAT wins a HUGE new contract from DaimlerChrysler.
****Contract might be worth about $25M/year!!!!
DaimlerChrysler Awards Significant New Powertrain Business to a Newcor Subsidiary
Monday May 9, 5:35 pm ET
LAS VEGAS, May 9 /PRNewswire-FirstCall/ -- EXX INC (Amex: EXX-A; EXX-B) today reported that one of the subsidiaries of Newcor, Inc. (a 99% owned subsidiary of EXX INC) has received purchase orders from DaimlerChrysler Corporation (DCX) to machine axles for two current powertrain programs. The anticipated sales would approximate a 20% increase over EXX's current sales and profitability on an annual basis. Production under the contracts is planned to begin shortly and build up to full production levels in the fourth quarter of 2005.
Here is the link for the announcement:
http://biz.yahoo.com/prnews/050509/dam061.html?.v=4
+++++ Highlights ++++++
* P/E = 14.5
* P/S = 0.16
* LOW FLOAT = 4.7 MILLION SHARES
* 2004 REVENUES = $143 MILLION
* 2004 NET INCOME = $1.5 MILLION
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $16 MILLION
* HEAVY INSIDER BUYING
* AMEX SYMBOL: EXX/A
Key Statistics :
http://finance.yahoo.com/q/ks?s=EXX-A
EXX Inc. (AMEX:EXX/A) should be trading above $10 just looking at all the numbers above. I suspect it is because the CEO does not want us to know about this company. That way he and his two daughters can buy the entire float. The three of them bought over 5% of the float in the open market in recent months. Together they now own 54% of the company. Maybe they knew of the impending DaimlerChrysler contract??.
Newcor Inc., a large EXXA subsidiary is in the hot precision-machined components industry. EXXA reminds me a lot of HURC a little over a year ago when it was trading in the $2 range. Like EXXA, HURC was also a thinly-traded obscure little company at the time.
The company through its strong cash flow has decreased its long-term debt substantially over the last two years. In 2004, Newcor repaid $8,793,000 principal amount of long-term debt. In 2003, Newcor repaid $10,462,000 principal amount of long term debt. The company’s current debt stands now at $29.2M compared to its total assets of over $90M.
To buy EXXA shares you need to enter EXX/A in your equity order form. I could not get the right symbol for a while and you might have the same problem until you figure it out. That might be another reason why EXXA has been under the radar for so long despite its strong fundamentals.
ABOUT EXX Inc.
EXX INC., through its subsidiaries, designs, produces, and sells electric motors geared toward the original equipment market, as well as designs, produces, and sells cable pressurization equipment for the telecommunications industry. The Company also designs, produces, and sells toys, watches, and kites for consumer markets.
Newcor Inc., one of EXXA's largest subsidiaries operates seven companies employing over 1,000 people in virtually all areas of design, engineering, and manufacturing of a variety of products, principally for the automotive, heavy-duty, agricultural and industrial markets.
Newcor focuses in two areas: precision machined components and molded rubber and plastic products. Newcor reports its businesses under two product segments: Precision Machined Products and Rubber and Plastic Products. Newcor also operates the Bay City Division, which designs and builds state-of-art welding and forming equipment.
DYNT $1.8 PROFITABLE and GROWING. EARNINGS TOMORROW.
DYNT will release its quarterly report on 5/11 before the market opens...
+++++ INVESTMENT HIGHLIGHTS ++++++
* DYNT IS A CONSISTENTLY PROFITABLE MEDICAL DEVICE COMPANY. PROFITABLE EVERY QUARTER!!
* UNDERVALUED. TRADING AT 0.7 P/S COMPARED TO INDUSTRY AVERAGE OF 3.4. MARKET CAP IS ONLY $15 MILLION.
* SOLID BALANCE SHEET WITH NO LONG-TERM DEBT.
* ONLY 7 MILLION SHARES IN THE FLOAT.
* MANY NEW PRODUCTS IN THE PIPELINE TO BE LAUNCHED THIS SUMMER.
* NEW PRODUCTS WILL INCREASE REVENUES BY AT LEAST 20% ACCORDING TO COMPANY.
* DURING THE LAST Q CC, DYNT's CEO SAID THAT TERRELL OWENS USED DYNATRONICS' FDA-APPROVED LIGHT THERAPY DURING HIS INTESIVE REHAB TO GET HIM WELL/READY FOR THE SUPERBOWL!!!.
The most interesting item I've heard during the last Quarter CC was that Terrell Owens was treated with Dynatronics Solaris FDA-approved Light Therapy for pain treatment, arthritis, osteoarthritis, and carpal syndrome.
Light therapy is a non-invasive, no side effect arthritis treatment. Right after last quarter, DYNT's light therapy gained a lot of visibility as a result of the adverse publicity received by competitors VIOXX and Celebrex.
To get the word out about the benefits of light therapy over VIOXX/Celebrex/other medications, they have renowned pain-management experts holding seminars around the country to educate patients suffering of pain, arthritis, carpal syndrome of the benefits on the non-intrusive, no-side-effect light therapy by Dynatronics.
Another significant comment made by the CEO is that he expects revenues to increase by at least 20% after the release of new products this summer. New products usually mean higher gross margins and higher net income.
The company received CE certification in Europe (equivalent to the FDA in the US) to market its light therapy products.
ADOUT DYNT:
Dynatronics (Nasdaq: DYNT) manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www dynatronics com.
NYER $2.05... 1.2M FLOAT... EARNINGS THIS WEEK
GREAT ENTRY POINT..... PROFITABLE LOW-FLOAT ROCKET!
* CONSISTENTLY PROFITABLE
* ULTRA LOW FLOAT - 1.2M SHARES
* STRONG BALANCE SHEET.
* MARKET CAP OF $8M
* REVENUES OF > $60M/YEAR
* P/S OF ONLY 0.13...SUPER UNDERVALUED!!!
ABOUT NYER:
Nyer Medical Group, Inc. is a holding company with operations in segments, including, pharmacies, medical and surgical equipment and supplies, and corporate. Through D.A.W., Inc., an 80%-owned subsidiary of the Company, it operates a chain of pharmacy drug stores in the suburban Boston, Massachusetts area. The Company's three wholly owned subsidiaries, ADCO Surgical Supply, Inc. (ADCO), ADCO South Medical Supplies, Inc. (ADCO South) and Nyer Internet Companies, Inc. (Internet) are engaged in the wholesale and retail sale of medical and surgical equipment and supplies throughout New England, Florida, Nevada and worldwide through the Internet sales.
DYNT $1.75. PROFITABLE. EARNINGS tomorrow 5/11
DYNT will release its quarterly report on 5/11 before the market opens...
+++++ INVESTMENT HIGHLIGHTS ++++++
* DYNT IS A CONSISTENTLY PROFITABLE MEDICAL DEVICE COMPANY. PROFITABLE EVERY QUARTER!!
* UNDERVALUED. TRADING AT 0.7 P/S COMPARED TO INDUSTRY AVERAGE OF 3.4. MARKET CAP IS ONLY $15 MILLION.
* SOLID BALANCE SHEET WITH NO LONG-TERM DEBT.
* ONLY 7 MILLION SHARES IN THE FLOAT.
* MANY NEW PRODUCTS IN THE PIPELINE TO BE LAUNCHED THIS SUMMER.
* NEW PRODUCTS WILL INCREASE REVENUES BY AT LEAST 20% ACCORDING TO COMPANY.
* DURING THE LAST Q CC, DYNT's CEO SAID THAT TERRELL OWENS USED DYNATRONICS' FDA-APPROVED LIGHT THERAPY DURING HIS INTESIVE REHAB TO GET HIM WELL/READY FOR THE SUPERBOWL!!!.
The most interesting item I've heard during the last Quarter CC was that Terrell Owens was treated with Dynatronics Solaris FDA-approved Light Therapy for pain treatment, arthritis, osteoarthritis, and carpal syndrome.
Light therapy is a non-invasive, no side effect arthritis treatment. Right after last quarter, DYNT's light thereapy gainED a lot of visibility as a result of the adverse publicity received by competitors VIOXX and Celebrex.
To get the word out about the benefits of light therapy over VIOXX/Celebrex/other medications, they have renowned pain-management experts holding seminars around the country to educate patients suffering of pain, arthritis, carpal syndrome of the benefits on the non-intrusive, no-side-effect light therapy by Dynatronics.
Another significant comment made by the CEO is that he expects revenues to increase by at least 20% after the release of new products this summer. New products usually mean higher gross margins and higher net income.
The company received CE certification in Europe (equivalent to the FDA in the US) to market its light therapy products.
ADOUT DYNT:
Dynatronics (Nasdaq: DYNT) manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www dynatronics com.
GIGM $1.5 EARNINGS THIS WEEK.
++++++ INVESTMENT HIGHLIGHTS +++++++++
* UNDERVALUED......TRADING @ 0.65 P/S RATIO
* UPDATED GUIDANCE: PROFITABLE FOR 4Q AND FY 2004
* STRONG BALANCE SHEET: $1.4/SHARE CASH..NO LT DEBT...$1.8/SHARE SHAREHOLDERS' EQUITY.
* INSIDERS OWN 57% OF COMPANY.
* INSTITUTIONS RAISED THEIR HOLDINGS BY 35% LAST QUARTER.
On April 13, 2005, GIGN said that it will post a profit for 2004. The company also said that it will record a profit for the fourth quarter.
The company plans to report year-end results in mid-May. on April 13, GIGM shares rose 8 cents, or 5.3 percent, to $1.60 in morning trading on the Nasdaq.
As a comparison, GIGM posted a loss of $14.3 M in 2003.
GIGM should go up this week because of the impressive turnaround in its financial results.... its VERY strong balance sheet.....and because it is grossly undervalued at these prices.
ABOUT GIGM:
GigaMedia, via subsidiary G-Music, operates Taiwan's top music store chains, Rose Records and Tachung Records (about 50 locations). The company also owns a profitable and growing on-line gaming software development company, Grand Virtual (located in Boston), which it purchased in April 2004. Subsidiary Hoshin GigaMedia and it's subsidiary, Koos Broadband Telecom, provide broadband Internet services via cable and DSL connections throughout Taiwan, as well as running numerous Chinese-language Internet portals.
In October 2005, GIGM announced the expansion of the Company's corporate ISP product line to include ON-NET. Developed by GigaMedia and Hutchison Global Communications Limited ("HGC"), ON-NET offers telecommunication network services that address the challenges businesses in Taiwan, Hong Kong and China are having resulting from regional growth and development.
GigaMedia and HGC estimate that there are currently more than 60,000 businesses in Taiwan with operations in Hong Kong and China. This regional economic integration is driving significant telecommunication demand. ON-NET services target the gap left by existing telecom services that do not address the fundamental challenges of network integration caused by regional business expansion -- connecting remote branch offices and project teams to the main corporate network simply, securely and efficiently. There are numerous other networking services available, but ON-NET is exceptional in its design. Before this, no other international telecommunication services offered between Taiwan, Hong Kong and China featured the cross-cities, metro Ethernet architecture of ON-NET.
VSNT $0.59. URGENT BUY ALERT. PROFITABLE/IMPROVING FUNDAMENTALS
MMs are having a ball with VSNT lately...and so am I. I've been loading up today big time as these SOBs keep finding stop after stop. I see two-bagger here ...easily!!
I believe all of the recent sales, and pps drop, come from nervous retailers bailing out. Institutional buying made up 36% of the buying in the last 30 days according to I-Watch.
VSNT is a profitable company with strong balance sheet and a technology leader in the field of object-based and relational data management systems. Its latest product Open Access.NET has been featured in Microsoft On-line Magazine as No. 1 news, and was launched last month at this year's CeBIT show/conference in Germany in Microsoft's booth.
On 3/9/05, VSNT reported record Fiscal 1Q revenues and net income on the high end of guidance.
Earnings Summary:
* VSNT reported record 1Q revenues of $6.6 million...on the high end of the $6.2 to $6.7 revenue guidance.
* VSNT reported net income of $345K, also on the high end of the breakeven to 1c/share net income guidance.
* VSNT reported positive cash flow. Gross margin increased from 66% to 67% compared to 1Q 2004.
* VSNT has a strong balance sheet with $3.6 Million in cash, no long-term debt, and about 80c/share shareholder's equity.
* VSNT reported a number of new customers including: Addison, Lucent, Dell, Eriksson, Cable Deutsch, Bea Systems, Lockhead, Statoil, SBC, MCI and many others.
* Guidance for FY fiscal 2005 is for revenue growth and profitable and positive cash flow in every quarter.
CEO Nick Ordon said during the CC that during the 1Q 2005, Versant booked the highest revenue in several years from PeopleSoft due to the increased sales of PeopleSoft's products using Versant's technology. Last December, VSNT went through the roof when the company announced an expanded relationship with PeopleSoft. CEO ordon said that the Oracle acquisition of PeopleSoft has had no adverse effect on the agreement.
More on Versant (from PR):
Versant Corporation's principal product is the Versant Developer Suite (VDS), a sixth-generation object database management system. Its other products include Versant enJin, a database management product suite that accelerates transactions for application servers; Versant Real-Time Framework (VRTF), a comprehensive framework for delivering real-time solutions, and Versant JDO, a data access tool that enables enterprise applications to efficiently access data from a versant object database. Versant licenses VDS, Versant enJin and peripheral products, and sells associated maintenance, training and consulting services to end users. Versant newest product, Open Access .NET started shipping on 3/10/2005..
VSNT $0.59. URGENT BUY ALERT. PROFITABLE/IMPROVING FUNDAMENTALS
MMs are having a ball with VSNT lately...and so am I. I've been loading up today big time as these SOBs keep finding stop after stop. I see two-bagger here ...easily!!
I believe all of the recent sales, and pps drop, come from nervous retailers bailing out. Institutional buying made up 36% of the buying in the last 30 days according to I-Watch.
VSNT is a profitable company with strong balance sheet and a technology leader in the field of object-based and relational data management systems. Its latest product Open Access.NET has been featured in Microsoft On-line Magazine as No. 1 news, and was launched last month at this year's CeBIT show/conference in Germany in Microsoft's booth.
On 3/9/05, VSNT reported record Fiscal 1Q revenues and net income on the high end of guidance.
Earnings Summary:
* VSNT reported record 1Q revenues of $6.6 million...on the high end of the $6.2 to $6.7 revenue guidance.
* VSNT reported net income of $345K, also on the high end of the breakeven to 1c/share net income guidance.
* VSNT reported positive cash flow. Gross margin increased from 66% to 67% compared to 1Q 2004.
* VSNT has a strong balance sheet with $3.6 Million in cash, no long-term debt, and about 80c/share shareholder's equity.
* VSNT reported a number of new customers including: Addison, Lucent, Dell, Eriksson, Cable Deutsch, Bea Systems, Lockhead, Statoil, SBC, MCI and many others.
* Guidance for FY fiscal 2005 is for revenue growth and profitable and positive cash flow in every quarter.
CEO Nick Ordon said during the CC that during the 1Q 2005, Versant booked the highest revenue in several years from PeopleSoft due to the increased sales of PeopleSoft's products using Versant's technology. Last December, VSNT went through the roof when the company announced an expanded relationship with PeopleSoft. CEO ordon said that the Oracle acquisition of PeopleSoft has had no adverse effect on the agreement.
More on Versant (from PR):
Versant Corporation's principal product is the Versant Developer Suite (VDS), a sixth-generation object database management system. Its other products include Versant enJin, a database management product suite that accelerates transactions for application servers; Versant Real-Time Framework (VRTF), a comprehensive framework for delivering real-time solutions, and Versant JDO, a data access tool that enables enterprise applications to efficiently access data from a versant object database. Versant licenses VDS, Versant enJin and peripheral products, and sells associated maintenance, training and consulting services to end users. Versant newest product, Open Access .NET started shipping on 3/10/2005..
IOX $2.28 Will Report Earnings Results This Week (4/25 - 4/29)
4M FLOAT BIOTEC...$1.3/SHARE CASH...CONSISTENTLY PROFITABLE...
IOMED (AMEX: IOX) is a low-float, consistently profitable biotec company and a leader in the development, manufacture and sale of active transdermal drug delivery systems. The company has reported 10 consecutive profitable quarters.
IOX has been increasing its Shareholders Equity ($1.5/share), Cash ($1.3/share), and Working Capital ($1.3/share) every year for the last three years.
IOX is undervalued under $4/share...you'll agree with me after you do your DD on this gem.
IOX's stock price never recovered after ELN, IOX largest shareholder until recently, begun selling big lots of stock with regularity in the spring/summer of 2004.
....ELN IS NOW FOREVER GONE...NO MORE SHORTING HERE!!
Three weeks ago, ELN sold its entire stake in IOX to The Ridgestone Corp. (a family trust). The Ridgestone Corp. in turn has put immediate pressure on IOX management to increase shareholder value.
According to Barrons, .. "Ridgestone Corp. wants Iomed to use its "significant cash balance more effectively." Ridgestone offered several options that, it asserts, would enhance shareholder value. Among them: acquiring a complementary business. If no suitable acquisitions are available, Ridgestone wants the company to make a one-time distribution of at least $6 million in cash to shareholders and to repurchase some of its shares. Ridgestone owns 1,058,400 million shares (16.1%)...." For more details, please read the latest IOX filing:
http://www.sec.gov/Archives/edgar/data/1041652/000110465905015712/a05-6501_1ex2.htm
IOMED (AMEX IOX) develops, manufactures and markets proprietary, advanced drug delivery systems used in the site-specific, active transdermal administration of a variety of drug compounds. The company's current products are used primarily for site-specific corticosteroid therapy in clinics nationwide to treat a variety of local inflammatory conditions, including those suffered by top professional and semi-professional athletes in football, baseball, basketball, hockey, golf and skiing. Clinicians have administered over 22 million patient treatments using IOMED's systems.
Its proprietary system is called the Phoresor System, which is designed for clinical use and is comprised of a patented didgital reusable dose controller and single-use, disposable electrode kits.
The company's active drug delivery systems employ iontophoresis as a non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs, into and through the skin and other body tissues using a low-level direct electrical current.
Using its proprietary technology, IOMED has also developed an ocular drug delivery system that seeks to address the safe and effective administration of therapeutics to the back of the eye. The company's delivery system, trademarked OcuPhor, allows for the non-invasive, site-specific administration of a therapeutic agent without the collateral tissue damage associated with surgery, lasers, needle injections, or implants.
Feasibility studies confirmed OcuPhor's ability to deliver a broad range of anti-angiogenic drugs to the back of the eye. Preliminary clinical studies in human volunteers have shown that the OcuPhor System is both safe and well tolerated as measured by a series of standard tests. Additionally, the company has demonstrated that the OcuPhor system is capable of delivering anti-angiogenic, anti-inflammatory, antibiotic, and antiviral compounds.
The company is seeking license agreements and collaborative partnerships to advance the clinical and commercial development of the OcuPhor system and other potential therapeutic applications of its drug delivery technology.
IOX $2.28 Will Report Earnings Results This Week (4/25 - 4/29)
4M FLOAT BIOTEC...$1.3/SHARE CASH...CONSISTENTLY PROFITABLE...
IOMED (AMEX: IOX) is a low-float, consistently profitable biotec company and a leader in the development, manufacture and sale of active transdermal drug delivery systems. The company has reported 10 consecutive profitable quarters.
IOX has been increasing its Shareholders Equity ($1.5/share), Cash ($1.3/share), and Working Capital ($1.3/share) every year for the last three years.
IOX is undervalued under $4/share...you'll agree with me after you do your DD on this gem.
IOX's stock price never recovered after ELN, IOX largest shareholder until recently, begun selling big lots of stock with regularity in the spring/summer of 2004.
....ELN IS NOW FOREVER GONE...NO MORE SHORTING HERE!!
Three weeks ago, ELN sold its entire stake in IOX to The Ridgestone Corp. (a family trust). The Ridgestone Corp. in turn has put immediate pressure on IOX management to increase shareholder value.
According to Barrons, .. "Ridgestone Corp. wants Iomed to use its "significant cash balance more effectively." Ridgestone offered several options that, it asserts, would enhance shareholder value. Among them: acquiring a complementary business. If no suitable acquisitions are available, Ridgestone wants the company to make a one-time distribution of at least $6 million in cash to shareholders and to repurchase some of its shares. Ridgestone owns 1,058,400 million shares (16.1%)...." For more details, please read the latest IOX filing:
http://www.sec.gov/Archives/edgar/data/1041652/000110465905015712/a05-6501_1ex2.htm
IOMED (AMEX IOX) develops, manufactures and markets proprietary, advanced drug delivery systems used in the site-specific, active transdermal administration of a variety of drug compounds. The company's current products are used primarily for site-specific corticosteroid therapy in clinics nationwide to treat a variety of local inflammatory conditions, including those suffered by top professional and semi-professional athletes in football, baseball, basketball, hockey, golf and skiing. Clinicians have administered over 22 million patient treatments using IOMED's systems.
Its proprietary system is called the Phoresor System, which is designed for clinical use and is comprised of a patented didgital reusable dose controller and single-use, disposable electrode kits.
The company's active drug delivery systems employ iontophoresis as a non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs, into and through the skin and other body tissues using a low-level direct electrical current.
Using its proprietary technology, IOMED has also developed an ocular drug delivery system that seeks to address the safe and effective administration of therapeutics to the back of the eye. The company's delivery system, trademarked OcuPhor, allows for the non-invasive, site-specific administration of a therapeutic agent without the collateral tissue damage associated with surgery, lasers, needle injections, or implants.
Feasibility studies confirmed OcuPhor's ability to deliver a broad range of anti-angiogenic drugs to the back of the eye. Preliminary clinical studies in human volunteers have shown that the OcuPhor System is both safe and well tolerated as measured by a series of standard tests. Additionally, the company has demonstrated that the OcuPhor system is capable of delivering anti-angiogenic, anti-inflammatory, antibiotic, and antiviral compounds.
The company is seeking license agreements and collaborative partnerships to advance the clinical and commercial development of the OcuPhor system and other potential therapeutic applications of its drug delivery technology.
IOX $2.35 up 7% on heavier than usual volume
IOX $2.35 UP 7% on heavier than usual volume.
IOX $2.2 PROFITABLE LOW-FLOAT BIOTEC. KEEP AN EYE ON IT!!
According to Barrons, IOX will report its 3Q 2005 earnings results in the 4/25/05 and 4/29/05 time frame.
IOMED (AMEX: IOX) is a low-float, consistently profitable biotec company and a leader in the development, manufacture and sale of active transdermal drug delivery systems. The company has reported 10 consecutive profitable quarters. IOX reported net income of $363,000, or $0.05 per diluted share, for the first half of fiscal 2005, compared with net income of $330,000, or $0.04 per diluted share, in the comparable prior-year period. Revenues in 2Q 2005, as forewarned by the company, were weaker than most quarters due to a reorganization of its dealer network. The company expects improved performance in the last two quarters of 2005 because of an improved dealer network and strong sales of new products launched within the last 2 quarters.
The Company generated operating cash flow of $651,000 during the first half of fiscal 2005. Since June 30, 2004, working capital has increased $560,000 to $8.7 million. Shareholders' equity increased $363,000 to $9.8 million during that time. Total cash, including restricted cash, as of December 31, 2004 was $8.7 million or $1.3/share. IOX's current float is only about 4 million shares.
IOX is undervalued under $4/share if you consider that it is consistent profitable, it has a very strong balance sheet, and it is a leader in its niche market..and don't forget, its very low float.
IOX's stock price never recovered after ELN, IOX's largest shareholder until recently, started selling big chunks of stocks with regularity in the spring/summer of 2004 (see bottom weekly chart).
http://stockcharts.com/gallery/?iox
Investors can not be blamed for not wanting to invest in IOX because of the in fear that ELN could start dumping shares any day. That has changed 180 degrees recently. The Ridgestone Corp. (essentially a trust) has acquired all of the remaining ELN shares (and more) two weeks ago. According to Barrons, .. "Ridgestone Corp. wants Iomed to use its "significant cash balance more effectively." Ridgestone offered several options that, it asserts, would enhance shareholder value. Among them: acquiring a complementary business. If no suitable acquisitions are available, Ridgestone wants the company to make a one-time distribution of at least $6 million in cash to shareholders and to repurchase some of its shares. Ridgestone owns 1,058,400 million shares (16.1%)...." For more details, please read the latest IOX filing:
http://www.sec.gov/Archives/edgar/data/1041652/000110465905015712/a05-6501_1ex2.htm
What a change! From a troubled company like ELN essentially shorting the stock, to a proactive entity putting immediate pressure on management to increase shareholder value.
I expect good things for IOX in the future. The upcoming 3Q 2005 earnings release is sure to be a major improvement over the 2Q revenue/income results based on the comments of the company CEO in the last two earnings releases.
Take a look at IOX's strong financial performance:
http://finance.yahoo.com/q/is?s=IOX&annual
Also view the company's strong balance sheet:
http://finance.yahoo.com/q/bs?s=IOX
IOMED (AMEX IOX) is a medical device company involved in developing, manufacturing, and marketing of proprietary drug-delivery systems employing the principle known as iontophoresis. Iontophoresis is an effective and painless non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs into and through the skin and other body tissues using a low-level electrical current. IOMEDs patented products are to avoid the pain/infection that may accompany needle insertion.
IOX $2.2 PROFITABLE LOW-FLOAT BIOTEC. KEEP AN EYE ON IT!!
According to Barrons, IOX will report its 3Q 2005 earnings results in the 4/25/05 and 4/29/05 time frame.
IOMED (AMEX: IOX) is a low-float, consistently profitable biotec company and a leader in the development, manufacture and sale of active transdermal drug delivery systems. The company has reported 10 consecutive profitable quarters. IOX reported net income of $363,000, or $0.05 per diluted share, for the first half of fiscal 2005, compared with net income of $330,000, or $0.04 per diluted share, in the comparable prior-year period. Revenues in 2Q 2005, as forewarned by the company, were weaker than most quarters due to a reorganization of its dealer network. The company expects improved performance in the last two quarters of 2005 because of an improved dealer network and strong sales of new products launched within the last 2 quarters.
The Company generated operating cash flow of $651,000 during the first half of fiscal 2005. Since June 30, 2004, working capital has increased $560,000 to $8.7 million. Shareholders' equity increased $363,000 to $9.8 million during that time. Total cash, including restricted cash, as of December 31, 2004 was $8.7 million or $1.3/share. IOX's current float is only about 4 million shares.
IOX is undervalued under $4/share if you consider that it is consistent profitable, it has a very strong balance sheet, and it is a leader in its niche market..and don't forget, its very low float.
IOX's stock price never recovered after ELN, IOX's largest shareholder until recently, started selling big chunks of stocks with regularity in the spring/summer of 2004 (see bottom weekly chart).
http://stockcharts.com/gallery/?iox
Investors can not be blamed for not wanting to invest in IOX because of the in fear that ELN could start dumping shares any day. That has changed 180 degrees recently. The Ridgestone Corp. (essentially a trust) has acquired all of the remaining ELN shares (and more) two weeks ago. According to Barrons, .. "Ridgestone Corp. wants Iomed to use its "significant cash balance more effectively." Ridgestone offered several options that, it asserts, would enhance shareholder value. Among them: acquiring a complementary business. If no suitable acquisitions are available, Ridgestone wants the company to make a one-time distribution of at least $6 million in cash to shareholders and to repurchase some of its shares. Ridgestone owns 1,058,400 million shares (16.1%)...." For more details, please read the latest IOX filing:
http://www.sec.gov/Archives/edgar/data/1041652/000110465905015712/a05-6501_1ex2.htm
What a change! From a troubled company like ELN essentially shorting the stock, to a proactive entity putting immediate pressure on management to increase shareholder value.
I expect good things for IOX in the future. The upcoming 3Q 2005 earnings release is sure to be a major improvement over the 2Q revenue/income results based on the comments of the company CEO in the last two earnings releases.
Take a look at IOX's strong financial performance:
http://finance.yahoo.com/q/is?s=IOX&annual
Also view the company's strong balance sheet:
http://finance.yahoo.com/q/bs?s=IOX
IOMED (AMEX IOX) is a medical device company involved in developing, manufacturing, and marketing of proprietary drug-delivery systems employing the principle known as iontophoresis. Iontophoresis is an effective and painless non-invasive method of enhancing and controlling the transport of water-soluble ionic drugs into and through the skin and other body tissues using a low-level electrical current. IOMEDs patented products are to avoid the pain/infection that may accompany needle insertion.
HSR $5.3....KEEP AN EYE ON IT NEXT WEEK..:)
HSR could become the next low-float rocket a la SIMC, CVV, GIGA, BOOM, CYD, ARTW, etc. THESE ARE ALL ULTRA-LOW FLOAT, PROFITABLE COMPANIES....AND UNDER THE RADAR UNTIL RECENTLY.
Unlike some of those hot stocks, HSR has been been a consistently profitable company.
Well, the cat is out of the bag now....HSR has gained 30% last week on increasing volume ahead of NEXT WEEK's EARNINGS REPORT:
http://stockcharts.com/gallery/?hsr
+++ HSR INVESTMENT SUMMARY:
* 1.6 Million Shares in Float . Insiders own 75% of Co.
* Net Income of 30 + c/share
* 60% Net income growth from 2003 in first 6 mo. Fiscal Year.
* P/E of 13. Market Cap only $33 million
* New $4 M/year contract (5-year contract) with the Navy Surface Warfare Center. Orders started shipping in March 2005. Will contribute to the top and bottom line of 1Q 2005 and beyond.
* Last quarter started shipping satellite electro-mechanical assemblies per multi-year, multi-million$$ contract with Boeing.
* Further growth will be fueled by the return of the space program with the launching of Space Shuttle Discovery and an ever growing defense/satellite industry.
* Many components of the Space Shuttle Discovery to be launched soon were provided by HSR because of proven reliability.
* HSR received an award for providing critical components for the MARS Exploration ROVERS.
* HRS has a strong balance sheet listing no long-term debt and over $2/share shareholders' equity.
More on Hi Shear (AMEX: HSR):
Hi Shear is an established and growing space and defense high-tech equipment/component provider.
Demand for Hi-Shear products for use in both the space and defense sectors continues to be supported by increased defense spending for reconnaissance satellites, defensive missiles and smart weapon systems.
Hi Shear's customers are some of largest space and defense contractors in the world such as NASA, Boeing, Raytheon, BEA Systems, EADS, Lockeed Martin, etc.
Hi Shear's products are well diversified serving the following sectors of the space and defense industry: Missile deffense systems, launch and space vehicles, aircraft ejection systems, tactical weapons, and navy acoustic devices.
On the financial side, in 2004 HSR reported revenues and gross margins of $16,419,000 and $5,180,000 million respectively. Net Income was $1,915,000 or $0.29 per share for the year reflecting improved product margin, and reduced interest cost.
So far in the first 6 months of fiscal 2004, HSR has reported revenues of $8.3 M and net income of $1.2M or 18c/share. Net income would have been higher had the company not invested heavily in infrastructure to support its new contracts.
http://finance.yahoo.com/q/is?s=HSR
Here is a look at HSR's strong balance sheet:
http://finance.yahoo.com/q/bs?s=HSR
Hi Shear's CEO recently said:
"During the year (2004) the Navy Surface Warfare Center awarded us two major long-term production contracts. The first contract is for the production over five years of up to 10,000 Acoustic Firing Devices, which provide a safe firing system for underwater demolition teams. The second contract is for five year production of electronic Firing Code Transmitters, which provide remote acoustic command actuation of the Acoustic Firing Device. These two contracts have a potential total of between $19 million and $25 million, depending on the usage of this new innovative military system.......scheduled to begin production in March 2005. "
Always do your own DD.
HSR $5.3....KEEP AN EYE ON IT NEXT WEEK..:)
HSR could become the next low-float rocket a la SIMC, CVV, GIGA, BOOM, CYD, ARTW, etc. THESE ARE ALL ULTRA-LOW FLOAT, PROFITABLE COMPANIES....AND UNDER THE RADAR UNTIL RECENTLY.
Unlike some of those hot stocks, HSR has been been a consistently profitable company.
Well, the cat is out of the bag now....HSR has gained 30% last week on increasing volume ahead of NEXT WEEK's EARNINGS REPORT:
http://stockcharts.com/gallery/?hsr
+++ HSR INVESTMENT SUMMARY:
* 1.6 Million Shares in Float . Insiders own 75% of Co.
* Net Income of 30 + c/share
* 60% Net income growth from 2003 in first 6 mo. Fiscal Year.
* P/E of 13. Market Cap only $33 million
* New $4 M/year contract (5-year contract) with the Navy Surface Warfare Center. Orders started shipping in March 2005. Will contribute to the top and bottom line of 1Q 2005 and beyond.
* Last quarter started shipping satellite electro-mechanical assemblies per multi-year, multi-million$$ contract with Boeing.
* Further growth will be fueled by the return of the space program with the launching of Space Shuttle Discovery and an ever growing defense/satellite industry.
* Many components of the Space Shuttle Discovery to be launched soon were provided by HSR because of proven reliability.
* HSR received an award for providing critical components for the MARS Exploration ROVERS.
* HRS has a strong balance sheet listing no long-term debt and over $2/share shareholders' equity.
More on Hi Shear (AMEX: HSR):
Hi Shear is an established and growing space and defense high-tech equipment/component provider.
Demand for Hi-Shear products for use in both the space and defense sectors continues to be supported by increased defense spending for reconnaissance satellites, defensive missiles and smart weapon systems.
Hi Shear's customers are some of largest space and defense contractors in the world such as NASA, Boeing, Raytheon, BEA Systems, EADS, Lockeed Martin, etc.
Hi Shear's products are well diversified serving the following sectors of the space and defense industry: Missile deffense systems, launch and space vehicles, aircraft ejection systems, tactical weapons, and navy acoustic devices.
On the financial side, in 2004 HSR reported revenues and gross margins of $16,419,000 and $5,180,000 million respectively. Net Income was $1,915,000 or $0.29 per share for the year reflecting improved product margin, and reduced interest cost.
So far in the first 6 months of fiscal 2004, HSR has reported revenues of $8.3 M and net income of $1.2M or 18c/share. Net income would have been higher had the company not invested heavily in infrastructure to support its new contracts.
http://finance.yahoo.com/q/is?s=HSR
Here is a look at HSR's strong balance sheet:
http://finance.yahoo.com/q/bs?s=HSR
Hi Shear's CEO recently said:
"During the year (2004) the Navy Surface Warfare Center awarded us two major long-term production contracts. The first contract is for the production over five years of up to 10,000 Acoustic Firing Devices, which provide a safe firing system for underwater demolition teams. The second contract is for five year production of electronic Firing Code Transmitters, which provide remote acoustic command actuation of the Acoustic Firing Device. These two contracts have a potential total of between $19 million and $25 million, depending on the usage of this new innovative military system.......scheduled to begin production in March 2005. "
Always do your own DD.
Bucfan & Lentinman..Thank you guys for your comments.
Researcher. Thank you for your comments.
S_P regarding HSR. NO way Jose...LOL.
I am waiting for $10 plus.
HSR $5.10....up 52c!! Wow!!
HSR $4.58. Big orders lining up in pre-market. No sellers. HSR is looking like it is ready to break out. Keep an eye on it.
HSR $4.58. Big orders lining up in pre-market. No sellers. HSR is looking like it is ready to break out. Keep an eye on it.
HSR closed at $4.58 up 17% today. There are only 3 more trading days until earnings for fiscal 3Q 2005 are released next week. This could be a really strong quarter because the company was scheduled to start shipping materials in March per the $20+ million Navy Surface Water Center contract. Next Q will be even bigger because it will include the Navy-contract revenues for the entire Q. This would add approximately $1M/Q of revenues and some nice profit.
Good luck and always do your own DD
HSR closed at $4.58 up 17% today. There are only 3 more trading days until earnings for fiscal 3Q 2005 are released next week. This could be a really strong quarter because the company was scheduled to start shipping materials in March per the $20+ million Navy Surface Water Center contract. Next Q will be even bigger because it will include the Navy-contract revenues for the entire Q. This would add approximately $1M/Q of revenues and some nice profit.
Good luck and always do your own DD
The new $20 million 5 year navy contract and Boeing's recent multi-million multi-year contract you are looking at a strong revenue growth going forward.
HSR $4.1 Up 19c. 1.6M FLOAT. PROFITABLE. URGENT BUY ALERT!!
HSR is starting to move up ahead of earnings. HSR will report 3Q 2005 earnings next week. KEEP AN EYE ON THIS ONE!!
With the renewed investor interest in low-float profitable companies, HSR could be the next rocket like SIMC, CVV, and GIGA recently. HSR is super undervalued at current prices and a complelling value short and long-term.
+++ HSR INVESTMENT SUMMARY:
* 1.6 Million Shares in Float . Insiders own 75% of Co.
* Net Income of 30 + c/share
* 60% Net income growth from 2003 in first 6 mo. Fiscal Year.
* P/E of 11. Market Cap only $27 million
* $4 M/year contract (5-year contract) with the Navy Surface Warfare Center. Orders started shipping in March 2005. Will contribute to the top and bottom line of 1Q 2005 and beyond.
* Last quarter started shipping satellite electro-mechanical assemblies per long-term contract with Boeing.
* Many components of the Space Shuttle Discovery to be launched soon were provided by HSR.
* Received award for providing critical components for the MARS Exploration ROVERS.
* Strong balance sheet with no long-term debt and over $2/share shareholders' equity.
About Hi Shear (AMEX: HSR):
Hi Shear is an established and growing space and defense high-tech equipment/component provider.
Demand for Hi-Shear products for use in both the space and defense sectors continues to be supported by increased defense spending for reconnaissance satellites, defensive missiles and smart weapon systems.
Hi Shear's customers are some of largest space and defense contractors in the world such as NASA, Boeing, Raytheon, BEA Systems, EADS, Lockeed Martin, etc.
Hi Shear's products are well diversified serving the following sectors of the space and defense industry: Missile deffense systems, launch and space vehicles, aircraft ejection systems, tactical weapons, and navy acoustic devices.
On the financial side, in 2004 HSR reported revenues and gross margins of $16,419,000 and $5,180,000 million respectively. Net Income was $1,915,000 or $0.29 per share for the year reflecting improved product margin, and reduced interest cost.
So far in the first 6 months of fiscal 2004, HSR has reported revenues of $8.3 M and net income of $1.2M or 18c/share. Net income would have been higher had the company not invested heavily in infrastructure to support its new contracts.
http://finance.yahoo.com/q/is?s=HSR
Here is a look at HSR's strong balance sheet:
http://finance.yahoo.com/q/bs?s=HSR
Hi Shear's CEO recently said:
"During the year (2004) the Navy Surface Warfare Center awarded us two major long-term production contracts. The first contract is for the production over five years of up to 10,000 Acoustic Firing Devices, which provide a safe firing system for underwater demolition teams. The second contract is for five year production of electronic Firing Code Transmitters, which provide remote acoustic command actuation of the Acoustic Firing Device. These two contracts have a potential total of between $19 million and $25 million, depending on the usage of this new innovative military system.......scheduled to begin production in March 2005. "
HSR $4.1 Up 19c. 1.6M FLOAT. PROFITABLE. URGENT BUY ALERT!!
HSR is starting to move up ahead of earnings. HSR will report 3Q 2005 earnings next week. KEEP AN EYE ON THIS ONE!!
With the renewed investor interest in low-float profitable companies, HSR could be the next rocket like SIMC, CVV, and GIGA recently. HSR is super undervalued at current prices and a complelling value short and long-term.
+++ HSR INVESTMENT SUMMARY:
* 1.6 Million Shares in Float . Insiders own 75% of Co.
* Net Income of 30 + c/share
* 60% Net income growth from 2003 in first 6 mo. Fiscal Year.
* P/E of 11. Market Cap only $27 million
* $4 M/year contract (5-year contract) with the Navy Surface Warfare Center. Orders started shipping in March 2005. Will contribute to the top and bottom line of 1Q 2005 and beyond.
* Last quarter started shipping satellite electro-mechanical assemblies per long-term contract with Boeing.
* Many components of the Space Shuttle Discovery to be launched soon were provided by HSR.
* Received award for providing critical components for the MARS Exploration ROVERS.
* Strong balance sheet with no long-term debt and over $2/share shareholders' equity.
About Hi Shear (AMEX: HSR):
Hi Shear is an established and growing space and defense high-tech equipment/component provider.
Demand for Hi-Shear products for use in both the space and defense sectors continues to be supported by increased defense spending for reconnaissance satellites, defensive missiles and smart weapon systems.
Hi Shear's customers are some of largest space and defense contractors in the world such as NASA, Boeing, Raytheon, BEA Systems, EADS, Lockeed Martin, etc.
Hi Shear's products are well diversified serving the following sectors of the space and defense industry: Missile deffense systems, launch and space vehicles, aircraft ejection systems, tactical weapons, and navy acoustic devices.
On the financial side, in 2004 HSR reported revenues and gross margins of $16,419,000 and $5,180,000 million respectively. Net Income was $1,915,000 or $0.29 per share for the year reflecting improved product margin, and reduced interest cost.
So far in the first 6 months of fiscal 2004, HSR has reported revenues of $8.3 M and net income of $1.2M or 18c/share. Net income would have been higher had the company not invested heavily in infrastructure to support its new contracts.
http://finance.yahoo.com/q/is?s=HSR
Here is a look at HSR's strong balance sheet:
http://finance.yahoo.com/q/bs?s=HSR
Hi Shear's CEO recently said:
"During the year (2004) the Navy Surface Warfare Center awarded us two major long-term production contracts. The first contract is for the production over five years of up to 10,000 Acoustic Firing Devices, which provide a safe firing system for underwater demolition teams. The second contract is for five year production of electronic Firing Code Transmitters, which provide remote acoustic command actuation of the Acoustic Firing Device. These two contracts have a potential total of between $19 million and $25 million, depending on the usage of this new innovative military system.......scheduled to begin production in March 2005. "
Thank You Genegene11803. I have a SIMC look-alike pick for next week. Keep an eye open for it pick because I will mention that it is a lot like SIMC. Those who buy soon after my reco will make the most. Others will have to chase it just like they they did SIMC, GIGA, and LANV because they are too arrogant to think straight (you know who you are on this board) and with an open mind.
Have a nice weekend Genegene.
SIMC reported record revenues and net income right before closing today!!!
There are only 2 million shares on the float. $6 plus here we go.... This baby will rock tomorrow.
Highlights:
SIMC doubled net income from 2003 to over $2 million to over 36c/share!!!
SIMC grew revenue 48% compared to 2003 to over $50 million!!.
Without the costs related to the new Mexico plant (almost $500K per 10K) the net income would have been 15c/share in 4Q 2004!!
All that money is going to the bottom line in 1Q 2005 to be reported in less than 6 weeks!!!
http://biz.yahoo.com/bw/050331/315740.html?.v=1
+++ SIMC INVESTMENT HIGHLIGHTS:
* 1.8 Million Shares in Float
* Revenues of over $50 million/year
* Net Income of 36c/share
* Market Cap only $25 million
* P/E = 9.5
* P/S = 0.5
About Simclar:
Simclar, Inc. is a contract manufacturer of electronic and electro-mechanical products. The Company's products are manufactured to customer specifications and designed for original equipment manufacturers (OEMs) and distributors in the data processing, telecommunications, instrumentation and food preparation equipment industries. Simclar's principal custom-designed products include complex printed circuit boards (PCBs), conventional and molded cables, wire harnesses and electro-mechanical assemblies. In addition, the Company provides OEMs with value-added, turnkey contract manufacturing services and total systems assembly and integration. It also delivers manufacturing and test engineering services and materials management, with flexible and service-oriented manufacturing and assembly services for its customers' high-tech and rapidly changing products.
Always do your own DD.
SIMC $4.3 UP 80C!!!...TOMORROW'S HUGE RUNNER. ONLY 2 MILLION FLOAT!!!
SIMC $4.3 UP 80C...TOMORROW WILL RUN WELL PAST $5...
Simclar, Inc. Announces Record Fiscal 2004 Profits
Thursday March 31, 3:12 pm ET
HIALEAH, Fla.--(BUSINESS WIRE)--March 31, 2005--Simclar, Inc. (NASDAQ:SIMC - News), a multi-plant electronics contract manufacturer, reported its results for the year ended December 31, 2004.
Revenue for 2004 was $53,582,487, up 48 percent from $36,187,105 in 2003. Slightly more than half (57.3%) of the increase in revenue was attributable to the acquisition in July of 2003 of our Mexican facility, and the balance was attributable to "organic" sales growth.
Pre-tax income increased by 134% to $3,435,621 in 2004, versus $1,463,528 in 2003.
Net income for the year was $2,341,780 or $.36 per share, compared to $1,106,321 or $.17 per share, in 2003.
Simclar Chairman Sam Russell commented: "The progress in the area of cost containment made in previous years flowed through to the realization of record earnings in 2004. We were able to make some adjustments in the second half of the year even as raw materials costs were on the increase. We will continue to be vigilant in the area of cost containment, and we initiated programs in the latter part of 2004 to partner with suppliers who will work with us to decrease delivered materials costs.
"Our expanded facility in Matamoros, Mexico went on line in January of this year, and we are already supplying sheet metal to both new and existing customers.
"We continue to search for acquisitions which bring value to our Company and supplement the organic growth we have enjoyed through our ongoing Customer Cross-Fertilization Program."
Simclar, Inc., with five North American manufacturing locations, has been engaged in contract manufacturing of electronic and electro-mechanical products for OEMs for 29 years.
Statements in this news release, which relate to other than strictly historical facts, such as statements about the Company's plans and strategies, expectations for future financial performance, and markets for the Company's products and services are forward-looking statements. The words "believe," "expect," "anticipate," "estimate," "project," and similar expressions identify forward-looking statements that speak only as of the date hereof. Investors are cautioned that such statements involve risks and uncertainties that could cause actual results to differ materially from historical or anticipated results due to many factors including, but not limited to, the Company's customer concentration, debt covenants, competition, and other risks detailed in the Company's most recent Annual Report on Form 10-K and other Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
Visit Simclar, Inc. at its website, http://www.simclar.com
Simclar, Inc. Announces Record Fiscal 2004 Profits
Thursday March 31, 3:12 pm ET
HIALEAH, Fla.--(BUSINESS WIRE)--March 31, 2005--Simclar, Inc. (NASDAQ:SIMC - News), a multi-plant electronics contract manufacturer, reported its results for the year ended December 31, 2004.
Revenue for 2004 was $53,582,487, up 48 percent from $36,187,105 in 2003. Slightly more than half (57.3%) of the increase in revenue was attributable to the acquisition in July of 2003 of our Mexican facility, and the balance was attributable to "organic" sales growth.
Pre-tax income increased by 134% to $3,435,621 in 2004, versus $1,463,528 in 2003.
Net income for the year was $2,341,780 or $.36 per share, compared to $1,106,321 or $.17 per share, in 2003.
Simclar Chairman Sam Russell commented: "The progress in the area of cost containment made in previous years flowed through to the realization of record earnings in 2004. We were able to make some adjustments in the second half of the year even as raw materials costs were on the increase. We will continue to be vigilant in the area of cost containment, and we initiated programs in the latter part of 2004 to partner with suppliers who will work with us to decrease delivered materials costs.
"Our expanded facility in Matamoros, Mexico went on line in January of this year, and we are already supplying sheet metal to both new and existing customers.
"We continue to search for acquisitions which bring value to our Company and supplement the organic growth we have enjoyed through our ongoing Customer Cross-Fertilization Program."
Simclar, Inc., with five North American manufacturing locations, has been engaged in contract manufacturing of electronic and electro-mechanical products for OEMs for 29 years.
Statements in this news release, which relate to other than strictly historical facts, such as statements about the Company's plans and strategies, expectations for future financial performance, and markets for the Company's products and services are forward-looking statements. The words "believe," "expect," "anticipate," "estimate," "project," and similar expressions identify forward-looking statements that speak only as of the date hereof. Investors are cautioned that such statements involve risks and uncertainties that could cause actual results to differ materially from historical or anticipated results due to many factors including, but not limited to, the Company's customer concentration, debt covenants, competition, and other risks detailed in the Company's most recent Annual Report on Form 10-K and other Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
Visit Simclar, Inc. at its website, http://www.simclar.com
SIMC $3.5. 2 MILLION FLOATER. WILL REPORT TODAY
SIMC IS A PROFITABLE AND GROWING ULTRA LOW-FLOATER.....
SIMC will relese earnings TODAY within an hour according and before the market closes according to the company IR rep.
Virtually no shares for sale. MM's walking it down. This one will be $6 plus even with a so-so report. Higher if it is a good one.
+++ SIMC INVESTMENT HIGHLIGHTS:
* 1.8 Million Shares in Float
* Revenues of over $50 million/year
* Net Income of 36c/share
* Market Cap only $25 million
* P/E = 9.5
* P/S = 0.5
About Simclar:
Simclar, Inc. is a contract manufacturer of electronic and electro-mechanical products. The Company's products are manufactured to customer specifications and designed for original equipment manufacturers (OEMs) and distributors in the data processing, telecommunications, instrumentation and food preparation equipment industries. Simclar's principal custom-designed products include complex printed circuit boards (PCBs), conventional and molded cables, wire harnesses and electro-mechanical assemblies. In addition, the Company provides OEMs with value-added, turnkey contract manufacturing services and total systems assembly and integration. It also delivers manufacturing and test engineering services and materials management, with flexible and service-oriented manufacturing and assembly services for its customers' high-tech and rapidly changing products.
Always do your own DD.
SIMC $3.5 WILL REPORT TODAY BEFORE MARKET CLOSES
PROFITABLE AND GROWING ULTRA LOW-FLOATER.....
SIMC will relese earnings TODAY within an hour according and before the market closes according to the company IR rep.
Virtually no shares for sale. MM's walking it down. This one will be $6 plus even with a so-so report. Higher if it is a good one.
+++ SIMC INVESTMENT HIGHLIGHTS:
* 1.8 Million Shares in Float
* Revenues of over $50 million/year
* Net Income of 36c/share
* Market Cap only $25 million
* P/E = 9.5
* P/S = 0.5
About Simclar:
Simclar, Inc. is a contract manufacturer of electronic and electro-mechanical products. The Company's products are manufactured to customer specifications and designed for original equipment manufacturers (OEMs) and distributors in the data processing, telecommunications, instrumentation and food preparation equipment industries. Simclar's principal custom-designed products include complex printed circuit boards (PCBs), conventional and molded cables, wire harnesses and electro-mechanical assemblies. In addition, the Company provides OEMs with value-added, turnkey contract manufacturing services and total systems assembly and integration. It also delivers manufacturing and test engineering services and materials management, with flexible and service-oriented manufacturing and assembly services for its customers' high-tech and rapidly changing products.
Always do your own DD.
IPT $0.83 Up 14c ....WILL RUN BIG TIME THIS AFTERNOON
IPT 83c up 14c so far....
IPT $0.69 SIGNS A HUGE DEAL WITH BOSTON RED SOX!!!!
IPT will fly from these prices. This is a profitable, fast growing, grossly undervalued gem.
http://biz.yahoo.com/bw/050331/315061.html?.v=1
iParty Enters into Two-Year Sponsorship Agreement with the Boston Red Sox
Thursday March 31, 7:30 am ET
New England's Largest Party Retailer Now the Red Sox' ''Official Party Supply Store''
BOSTON--(BUSINESS WIRE)--March 31, 2005--The Boston Red Sox and iParty today announced a two-year sponsorship agreement whereby the region's pre-eminent party retailer will become the "official party supply store" of the World Champion Boston Red Sox. The announcement was made by Red Sox Chief Operating Officer Mike Dee and iParty CEO Sal Perisano. Says Perisano, "iParty is proud to be in business with The Boston Red Sox. Since our stores dominate the primary trade area of the Red Sox and since we are all in the business of celebration, we see this as a perfect match."
"As we accelerate the growth of our company, a visible sponsorship such as this broadens our reach to now include the husbands and children of those moms we've been targeting in our advertising," Perisano added.
Under the agreement, iParty will become the presenting sponsor of the Red Sox' Fenway Park Birthday Program. This program allows birthday celebrants (and their families/friends) to purchase a limited amount of ticket packages for a game at Fenway as well as to receive food and beverage for everyone in the party. iParty will add a complimentary gift for each participant as well. A happy birthday wish for the celebrants, sponsored by iParty, will be delivered on the main electronic scoreboard.
As part of the agreement, iParty will run several other Red Sox related promotions in its stores and construct an iParty Zone on designated home game dates throughout the season. All promotions will be supported by announcements on Red Sox television and radio broadcasts. iParty will also have a full page ad in all Red Sox program books over the two year period.
+++++++++INVESTMENT HIGHLIGHTS:
* Last month IPT reported record revenues of $23.7 Million and record net income of $2.7 Million for 4Q 2004. Fully-diluted market cap is only $24 Million.
* IPT has grown revenues and net income each of the last 4 years.
* IPT has posted a net profit each of the last two years.
* IPT is growing its store number at an average 18%/year.
* IPT's gross margins are among the highest in the sector consistently over 40%.
* IPT pays for new stores with its own cash and a line of credit. NO DILUTION.
* Insiders own 60% of the company. Low Float.
* IPT is Undervalued....trading at P/S of 0.15. Competitor BDAY is trading at P/S of 2.4.
Another way to look at IPT's phenomenal growth rate is to look at some of its statistics:
Revenues: 2004 = $64.3M; 2003 = $56.7M; 2002 = $52.1M; 2001 = $47M
Net Income: 2004 = $1.0M; 2003 = $0.8M; 2002 = $0.7M Loss; 2001 = $2.5M Loss
No. of Stores: 2004 = 45 2003 = 38; 2002 = 32; 2001 = 24
Projected Stores at the end of 2005 = 52...... Projected 2005 revenues of over $70 million!!!
According to Monster com, iParty is hiring heavily for new and existing stores. iParty's employment ads in Monster state:
.."... With aggressive plans underway to essentially double our size and our annual sales of $57 million over the next 5 years, we are inviting motivated management professionals to share in our explosive growth!...."
IPT $0.69 SIGNS A HUGE DEAL WITH BOSTON RED SOX!!!!
IPT will fly from these prices. This is a profitable, fast growing, grossly undervalued gem.
http://biz.yahoo.com/bw/050331/315061.html?.v=1
iParty Enters into Two-Year Sponsorship Agreement with the Boston Red Sox
Thursday March 31, 7:30 am ET
New England's Largest Party Retailer Now the Red Sox' ''Official Party Supply Store''
BOSTON--(BUSINESS WIRE)--March 31, 2005--The Boston Red Sox and iParty today announced a two-year sponsorship agreement whereby the region's pre-eminent party retailer will become the "official party supply store" of the World Champion Boston Red Sox. The announcement was made by Red Sox Chief Operating Officer Mike Dee and iParty CEO Sal Perisano. Says Perisano, "iParty is proud to be in business with The Boston Red Sox. Since our stores dominate the primary trade area of the Red Sox and since we are all in the business of celebration, we see this as a perfect match."
"As we accelerate the growth of our company, a visible sponsorship such as this broadens our reach to now include the husbands and children of those moms we've been targeting in our advertising," Perisano added.
Under the agreement, iParty will become the presenting sponsor of the Red Sox' Fenway Park Birthday Program. This program allows birthday celebrants (and their families/friends) to purchase a limited amount of ticket packages for a game at Fenway as well as to receive food and beverage for everyone in the party. iParty will add a complimentary gift for each participant as well. A happy birthday wish for the celebrants, sponsored by iParty, will be delivered on the main electronic scoreboard.
As part of the agreement, iParty will run several other Red Sox related promotions in its stores and construct an iParty Zone on designated home game dates throughout the season. All promotions will be supported by announcements on Red Sox television and radio broadcasts. iParty will also have a full page ad in all Red Sox program books over the two year period.
+++++++++INVESTMENT HIGHLIGHTS:
* Last month IPT reported record revenues of $23.7 Million and record net income of $2.7 Million for 4Q 2004. Fully-diluted market cap is only $24 Million.
* IPT has grown revenues and net income each of the last 4 years.
* IPT has posted a net profit each of the last two years.
* IPT is growing its store number at an average 18%/year.
* IPT's gross margins are among the highest in the sector consistently over 40%.
* IPT pays for new stores with its own cash and a line of credit. NO DILUTION.
* Insiders own 60% of the company. Low Float.
* IPT is Undervalued....trading at P/S of 0.15. Competitor BDAY is trading at P/S of 2.4.
Another way to look at IPT's phenomenal growth rate is to look at some of its statistics:
Revenues: 2004 = $64.3M; 2003 = $56.7M; 2002 = $52.1M; 2001 = $47M
Net Income: 2004 = $1.0M; 2003 = $0.8M; 2002 = $0.7M Loss; 2001 = $2.5M Loss
No. of Stores: 2004 = 45 2003 = 38; 2002 = 32; 2001 = 24
Projected Stores at the end of 2005 = 52...... Projected 2005 revenues of over $70 million!!!
According to Monster com, iParty is hiring heavily for new and existing stores. iParty's employment ads in Monster state:
.."... With aggressive plans underway to essentially double our size and our annual sales of $57 million over the next 5 years, we are inviting motivated management professionals to share in our explosive growth!...."
IPT $0.69 IS STARTING TO GET HOT. KEEP AN EYE ON THIS ONE.
iParty competitor Party City (PCTY) is up big time in AH today after announcing (3/30/05) that it is exploring merger Possibilities. Consolidation in the sector should help IPT ..the cheapest of the bunch at 0.15 X Sales...
http://biz.yahoo.com/ap/050330/party_city_ceo_strategy.html?.v=1
Another positive trend is that Institutions appear to be accumulating IPT lately...
http://thomson.finance.lycos.com/lycos/iwatch/cgi-bin/iw_ticker?t=IPT&am p;amp;range=30&mgp=0&hdate=&x=15&y=10
IPT usually goes up ahead of earnings. 1Q 2005 will be released in little over 2 weeks.
IPT recently reported record revenues and net income for 4Q 2004, and as it is often the case, it was rewarded by a sell-off (sounds familiar?). Investors sold off on the wrong belief that IPT's earnings would go down sustantially when it reports its 1Q 2005 results in April.
IPT is actually poised to post strong 1Q 2005 results for two big reasons:
* Easter, one of the biggest IPT revenue engines falls in 1Q 2005 (March) this year. The Easter-related sales will add substantially to the top and bottom line in 1Q 2005.
* There are 7 more stores compared to 1Q 2004. That will add another $2 million or so to 1Q 2004 totals based on estimated average per store revenues.
What does this mean?...
It simply means that IPT will likely report record 1Q 2005 revenues. Based on the company's current cost structure, IPT will likely report a for 1Q 2005 based. In other words, 1Q 2005 will be a substantial improvement over 1Q 2004.
+++++++++INVESTMENT HIGHLIGHTS:
* Last month IPT reported record revenues of $23.7 Million and record net income of $2.7 Million for 4Q 2004. Fully-diluted market cap is only $24 Million.
* IPT has grown revenues and net income each of the last 4 years.
* IPT has posted a net profit each of the last two years.
* IPT is growing its store number at an average 18%/year.
* IPT's gross margins are among the highest in the sector consistently over 40%.
* IPT pays for new stores with its own cash and a line of credit. NO DILUTION.
* Insiders own 60% of the company. Low Float.
* IPT is Undervalued....trading at P/S of 0.15. Competitor BDAY is trading at P/S of 2.4.
Another way to look at IPT's phenomenal growth rate is to look at some of its statistics:
Revenues: 2004 = $64.3M; 2003 = $56.7M; 2002 = $52.1M; 2001 = $47M
Net Income: 2004 = $1.0M; 2003 = $0.8M; 2002 = $0.7M Loss; 2001 = $2.5M Loss
No. of Stores: 2004 = 45 2003 = 38; 2002 = 32; 2001 = 24
Projected Stores at the end of 2005 = 52...... Projected 2005 revenues of over $70 million!!!
According to Monster com, iParty is hiring heavily for new and existing stores. iParty's employment ads in Monster state:
.."... With aggressive plans underway to essentially double our size and our annual sales of $57 million over the next 5 years, we are inviting motivated management professionals to share in our explosive growth!...."
More on IPT (from PR):
iParty Corp. (AMEX: IPT - news) is a party goods retailer which operates 45 iParty retail stores and licenses the operation of an Internet site for party goods and party planning at www iparty com. With over 20,000 party supplies and costumes and an online party magazine and party-related content, iParty offers consumers a sophisticated, yet fun and easy-to-use, resource with a definitive assortment of products to customize any party, including birthday bashes, Easter get-togethers, graduation parties, summer barbecues, and, of course, Halloween. iParty offers reliable, time-tested knowledge of party-perfect trends, and superior customer service to ensure convenient and comprehensive merchandise selections for every occasion.
Reminder: Always do your own DD. .
VSNT $0.76....NEW HOMELAND SECURITY/DEFENSE PLAY
SAGEM (and Versant) are Worldwide Leaders in Biometric Identification Systems - Homeland security, Defense, Law enforcement, and ID management.
*** Friday Press release.....Read:
http://biz.yahoo.com/prnews/050324/sfth033_4.html
More on VSNT:
VSNT received great news last week. Nasdaq granted the company 180 more days to regain full compliance (until September 12, 2005).
The possibility and the uncertainty of delisting was a dark cloud hanging over VSNT recently and a main contributor for the sell-off that occurred after the company posted record 1Q revenues and net income in the upper end of its guidance.
With a successful launch of its newest product, Open Access .NET, and strong sales of all existing products, VSNT will fly past $1 in the very near future IMO.
Versant launched Open Access .NET, in the Microsoft booth at CeBIT in Hanover, Germany, last week. Open Access .NET was featured last week as "Top News" in Microsoft's Online Magazine.
On 3/9/05, VSNT reported record Fiscal 1Q revenues and net income on the high end of guidance.
Earnings Summary:
* VSNT reported record 1Q revenues of $6.6 million...on the high end of the $6.2 to $6.7 revenue guidance.
* VSNT reported net income of $345K, also on the high end of the breakeven to 1c/share net income guidance.
* VSNT reported positive cash flow. Gross margin increased from 66% to 67% compared to 1Q 2004.
* VSNT has a strong balance sheet with $3.6 Million in cash, no long-term debt, and about 80c/share shareholder's equity.
* VSNT reported a number of new customers including: Addison, Lucent, Dell, Eriksson, Cable Deutsch, Bea Systems, Lockhead, Statoil, SBC, MCI and many others.
* Guidance for FY fiscal 2005 is for revenue growth and profitable and positive cash flow in every quarter.
CEO Nick Ordon said during the CC that during the 1Q 2005, Versant booked the highest revenue in several years from PeopleSoft due to the increased sales of PeopleSoft's products using Versant's technology. Last December, VSNT went through the roof when the company announced an expanded relationship with PeopleSoft. CEO ordon said that the Oracle acquisition of PeopleSoft has had no adverse effect on the agreement.
More on Versant (from PR):
Versant Corporation's principal product is the Versant Developer Suite (VDS), a sixth-generation object database management system. Its other products include Versant enJin, a database management product suite that accelerates transactions for application servers; Versant Real-Time Framework (VRTF), a comprehensive framework for delivering real-time solutions, and Versant JDO, a data access tool that enables enterprise applications to efficiently access data from a versant object database. Versant licenses VDS, Versant enJin and peripheral products, and sells associated maintenance, training and consulting services to end users. Versant newest product, Open Access .NET started shipping on 3/10/2005..